Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Neurostimulation in Ameliorating Symptoms of Neuropathic Corneal Pain

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Age \>22~2. Ability to consent to study.~3. Symptoms of neuropathic corneal pain for at least 3 months, such as burning, stinging, light sensitivity, discomfort or pain.~4. Positive in vivo confocal microscopy (IVCM) findings for NCP such as presence of microneuromas and decreased nerve density.~5. Fifty percent or more relief of pain or discomfort after instillation of Proparacaine eye drops as measured by the Visual Analogue Scale (VAS).~Exclusion Criteria:~1. Clinically significant acute ocular surface diseases, such as active infectious keratitis or recent ocular surgery in the past 3 months.~2. Chronic or recurrent epistaxis, coagulation disorders.~3. Nasal or sinus surgery or significant trauma to the nose.~4. Severe nasal airway obstruction or vascularized nasal polyps.~5. Cardiac demand pacemaker, implanted defibrillator, or other implanted electronic device in the head or neck.~6. Chronic or recurrent nosebleeds~7. Bleeding disorder~8. Known hypersensitivity (allergy) to the hydrogel material~9. Disabling arthritis, neuropathy, or limited motor coordination affecting self-handling of the device.

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).